Home
Conditions
Depressive Disorder, Major

Clinical trial condition

Depressive Disorder, Major

Explore clinical trials studying Depressive Disorder, Major. Study availability and eligibility vary by location and protocol.

2,300 public trials 326 recruiting studies

Refine in advanced search Browse all conditions

Depressive Disorder, Major trial results

Completed

Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach

NCT02553915

Conditions: Behavior, Behavioral Symptoms, Body Weight, +14 more
Locations: Emory University School of Medicine Atlanta, Georgia, United States

Depression Clinical and Research Program at Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept

NCT03715127

Conditions: Behavior, Behavioral Symptoms, Depression, +7 more
Locations: Psychiatrische Universitätsklinik Zürich Zurich, Switzerland

View Trial Details

Completed

Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression: OL Cohort

NCT03240692

Conditions: Depressive Disorder, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant, +3 more
Locations: Nolan Williams, MD Palo Alto, California, United States

View Trial Details

Completed

Contact: Developing New Clinical Management Strategies

NCT03812588

Conditions: Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations: New York State Psychiatric Institute New York, United States

View Trial Details

Completed

Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness

NCT02845440

Conditions: Behavior, Bipolar Disorder, Bipolar and Related Disorders, +12 more
Locations: Center for Addiction Medicine, Massachusetts General Hospital, Dept. of Psychiatry Boston, Massachusetts, United States

View Trial Details

Completed

Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder

NCT02484456

Conditions: Depressive Disorder, Depressive Disorder, Major, Major Depression, +2 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Comparative Effectiveness of Pharmacogenomics for Treatment of Depression

NCT03749629

Conditions: Behavior, Behavioral Symptoms, Depression, +5 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)

NCT01312922

Conditions: Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations: Site 103 Glendale, California, United States

Site 101 National City, California, United States

Site 113 Riverside, California, United States

Site 106 San Diego, California, United States

View all 31 locations

View Trial Details

Completed

Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression

NCT02624102

Conditions: Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations: Curt Hemanny Salvador, Estado de Bahia, Brazil

View Trial Details

Completed

Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies

NCT03283670

Conditions: Behavior, Behavioral Symptoms, Depression, +5 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Depressive Disorder, Major

Depressive Disorder, Major trial results

Related conditions